Compounds > gvs 111
Page last updated: 2024-09-05

gvs 111 and mecamylamine

gvs 111 has been researched along with mecamylamine in 1 studies

Compound Research Comparison

Studies
(gvs 111)		Trials
(gvs 111)		Recent Studies (post-2010)
(gvs 111)		Studies
(mecamylamine)		Trials
(mecamylamine)		Recent Studies (post-2010) (mecamylamine)
912311,99768376

Protein Interaction Comparison

ProteinTaxonomygvs 111 (IC50)mecamylamine (IC50)
Neuronal acetylcholine receptor subunit beta-2Homo sapiens (human)0.44
Neuronal acetylcholine receptor subunit beta-4Homo sapiens (human)2.0833
Neuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)1.6133
Neuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)1.8
Neuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)0.6
Neuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)3.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belnik, AP; Ostrovskaya, RU; Radionova, KS1

Other Studies

1 other study(ies) available for gvs 111 and mecamylamine

ArticleYear
Original nootropic drug noopept prevents memory deficit in rats with muscarinic and nicotinic receptor blockade.
    Bulletin of experimental biology and medicine, 2008, Volume: 146, Issue:1

    Topics: Animals; Cholinergic Agonists; Cholinergic Antagonists; Dipeptides; Male; Mecamylamine; Memory; Memory Disorders; Nicotinic Antagonists; Nootropic Agents; Rats; Scopolamine

2008